GIANT BIOGENE(02367),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02367 GIANT BIOGENE

Market Closed 05-15 16:09:05

29.320

-0.380

-1.28%

High29.920	Low29.040	Vol3.71M
Open29.720	D1 Closing29.700	Amplitude2.96%
Mkt Cap31.14B	Tradable Cap31.14B	Total Shares1.06B
T/O108.53M	T/O Rate0.35%	Tradable Shares1.06B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02367","market":"HK","secType":"STK","nameCN":"GIANT BIOGENE","latestPrice":29.32,"timestamp":1778832545004,"preClose":29.7,"halted":0,"volume":3708556,"delay":0,"changeRate":-0.012794612794612761,"floatShares":1061999999,"shares":1061999999,"eps":2.081616531553056,"marketStatus":"Market Closed","change":-0.38,"latestTime":"05-15 16:09:05","open":29.72,"high":29.92,"low":29.04,"amount":108526061,"amplitude":0.02963,"askPrice":29.32,"askSize":56200,"bidPrice":29.28,"bidSize":1200,"shortable":3,"etf":0,"ttmEps":2.081616531553056,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":7,"adr":0,"listingDate":1667491200000,"exchange":"SEHK","adjPreClose":29.7,"dividendRate":0.021151,"openAndCloseTimeList":[[1778808600000,1778817600000],[1778821200000,1778832000000]],"volumeRatio":0.736518567321199,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02367","defaultTab":"news","newsList":[{"id":"2633198332","title":"Giant Biogene Holding's (HKG:2367) Sluggish Earnings Might Be Just The Beginning Of Its Problems","url":"https://stock-news.laohu8.com/highlight/detail?id=2633198332","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633198332?lang=en_us&edition=fundamental","pubTime":"2026-05-07 06:56","pubTimestamp":1778108196,"startTime":"0","endTime":"0","summary":"The subdued market reaction suggests that Giant Biogene Holding Co., Ltd.'s ( HKG:2367 ) recent earnings didn't contain...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/household/hkg-2367/giant-biogene-holding-shares/news/giant-biogene-holdings-hkg2367-sluggish-earnings-might-be-ju","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/household/hkg-2367/giant-biogene-holding-shares/news/giant-biogene-holdings-hkg2367-sluggish-earnings-might-be-ju","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117585287","title":"Giant Biogene Plans Auditor Switch to KPMG, Unveils RMB1.21 Dividend Package and New Share Mandates","url":"https://stock-news.laohu8.com/highlight/detail?id=1117585287","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117585287?lang=en_us&edition=fundamental","pubTime":"2026-05-06 21:43","pubTimestamp":1778074993,"startTime":"0","endTime":"0","summary":"Giant Biogene Holding Co., Ltd. (Giant Biogene) will seek shareholder approval at its Annual General Meeting (AGM) on 28 May 2026 for several key resolutions, including a change of external auditor,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160125438","title":"Giant Biogene Sets 28 May 2026 AGM; Board Proposes RMB0.539 Final Dividend, RMB0.671 Special Dividend and Auditor Change to KPMG","url":"https://stock-news.laohu8.com/highlight/detail?id=1160125438","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160125438?lang=en_us&edition=fundamental","pubTime":"2026-05-06 21:43","pubTimestamp":1778074982,"startTime":"0","endTime":"0","summary":"Giant Biogene Holding Co., Ltd. has scheduled its annual general meeting for 28 May 2026 at 1:30 p.m. in Xi’an, Shaanxi Province. Key resolutions to be tabled include: • Financial Statements:...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128959314","title":"Giant Biogene to Hold 28 May 2026 AGM; Shareholders to Vote on FY 2025 Results, Director Re-election, Auditor Change, Share Mandates and RMB1.21 Dividend Package","url":"https://stock-news.laohu8.com/highlight/detail?id=1128959314","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128959314?lang=en_us&edition=fundamental","pubTime":"2026-05-06 21:42","pubTimestamp":1778074969,"startTime":"0","endTime":"0","summary":"Giant Biogene Holding Co., Ltd. has scheduled its 2025 annual general meeting for 28 May 2026 at 1:30 p.m. in Xi’an, Shaanxi Province. The proxy circular lists seven ordinary resolutions for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633013938","title":"Giant Biogene announces annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2633013938","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633013938?lang=en_us&edition=fundamental","pubTime":"2026-05-06 21:37","pubTimestamp":1778074673,"startTime":"0","endTime":"0","summary":"Giant Biogene schedules annual general meeting in Xi’an, China on May 28, 2026.Shareholders to consider 2025 audited financial statements, re-election of executive directors Fang Juan, Zhang Huijuan, Yan Yubo, and board authority to set directors’ remuneration.Vote set on appointing KPMG as independent auditor to replace Ernst & Young.Resolutions include share repurchase mandate capped at 10% of issued shares, share issuance mandate capped at 20%, and extension of issuance mandate by shares repurchased.Dividend proposals cover final dividend of RMB 0.5390 per ordinary share and special dividend of RMB 0.6714 per ordinary share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Giant Biogene Holding Co Ltd. published the original content u","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL39DVmG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367","SG9999004311.SGD","BK1207","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631634526","title":"Giant Biogene to replace EY with KPMG as auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2631634526","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631634526?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:03","pubTimestamp":1777550585,"startTime":"0","endTime":"0","summary":"Giant Biogene plans to replace auditor Ernst & Young with KPMG, ending EY’s seven-year tenure following audit of fiscal 2025 financial statements.Board resolved on April 30, 2026 not to reappoint EY, with retirement effective at conclusion of next annual general meeting.Audit committee recommended KPMG, with appointment subject to shareholder vote at annual general meeting.EY confirmed no matters related to its retirement require shareholder attention.Company expects no impact on fiscal 2025 audit or timing of fiscal 2026 annual audit and results.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Giant Biogene Holding Co Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL5dyZMc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004311.SGD","BK1207","LU2488822045.USD","02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141490016","title":"巨子生物2025年业绩：营收约55.19亿元，净利润达19.15亿元，多品牌与科研布局持续升级","url":"https://stock-news.laohu8.com/highlight/detail?id=1141490016","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141490016?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:25","pubTimestamp":1777465556,"startTime":"0","endTime":"0","summary":"巨子生物控股有限公司（GIANT BIOGENE）披露了2025年度业绩及相关报告。年内公司总收入约人民币55.19亿元，与上年基本持平；按国际财务报告准则（IFRS）计算的净利润约19.15亿元，同比下降7.1%；经调整后净利润约19.60亿元，同比下降8.9%。董事会建议派发末期及特别股息合计约人民币12.79亿元。...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"巨子生物2025年业绩：营收约55.19亿元，净利润达19.15亿元，多品牌与科研布局持续升级","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177722958","title":"GIANT BIOGENE’s 2025 ESG Report: Strong Governance, RMB 88.79 Million R&D Outlay and “National Green Factory” Recognition","url":"https://stock-news.laohu8.com/highlight/detail?id=1177722958","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177722958?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:23","pubTimestamp":1777465434,"startTime":"0","endTime":"0","summary":"GIANT BIOGENE (HKEX: 02367) has released its 2025 Environmental, Social and Governance (ESG) Report, detailing broad-based improvements in governance, product quality, environmental stewardship and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631519118","title":"Giant Biogene publishes 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631519118","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631519118?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:17","pubTimestamp":1777465047,"startTime":"0","endTime":"0","summary":"Giant Biogene released its 2025 ESG report, outlining a board-led, three-tier governance structure that ties ESG targets to KPI assessments.Materiality review identified 19 priority topics, including 8 rated high materiality across climate, hazardous chemicals, product quality, and data security.R&D spending totaled RMB 88.79 million in 2025, representing 1.6% of revenue.Quality program set core targets of first-inspection pass rate of at least 98.5% and customer satisfaction of at least 95%, with 0 product recall incidents reported.Supply chain oversight expanded supplier base to 366, including 80 suppliers with SA8000 certification.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Giant Biogene Holding Co Ltd. published the original co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDLbkz124:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","02367","SG9999004311.SGD","BK1207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166909557","title":"Giant Biogene Shares Extend Rally with Over 7% Surge Following CCTV Factory Feature","url":"https://stock-news.laohu8.com/highlight/detail?id=1166909557","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166909557?lang=en_us&edition=fundamental","pubTime":"2026-04-21 10:02","pubTimestamp":1776736941,"startTime":"0","endTime":"0","summary":"Giant Biogene (02367) saw its shares rise more than 7% again. At the time of writing, the stock was up 5.8%, trading at HK$31.38 with a turnover of HK$189 million. The momentum follows a deep-dive...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367","VXUS","SG9999004311.SGD","BK4588","LU2488822045.USD","BK4585","BK1207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165245695","title":"GIANT BIOGENE Cancels 9.2 Million Repurchased Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1165245695","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165245695?lang=en_us&edition=fundamental","pubTime":"2026-04-20 18:28","pubTimestamp":1776680908,"startTime":"0","endTime":"0","summary":"GIANT BIOGENE (02367) has announced the cancellation of 9.2 million shares that were previously repurchased by the company. The cancellation was executed on April 20, 2026.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1207","SG9999004311.SGD","02367","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628412737","title":"Giant Biogene files HKEX return disclosing share repurchase at HKD 35.94 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2628412737","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628412737?lang=en_us&edition=fundamental","pubTime":"2026-04-20 18:24","pubTimestamp":1776680676,"startTime":"0","endTime":"0","summary":"Giant Biogene filed HKEX next-day disclosure return covering cancellation of 9.2 million shares repurchased in Dec 2025 to Jan 2026.Repurchase prices averaged about HKD 33.6 to HKD 36.07 per share.Issued shares fell to 1,061,704,000 as of April 20, from 1,070,904,000.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Giant Biogene Holding Co Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL75NGBp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004311.SGD","LU2488822045.USD","BK1207","02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130687673","title":"Stock Track | Giant Biogene Soars 5.49% Intraday as Market Sentiment Recovers After Annual Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=1130687673","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130687673?lang=en_us&edition=fundamental","pubTime":"2026-04-20 11:09","pubTimestamp":1776654563,"startTime":"0","endTime":"0","summary":"Giant Biogene's stock price surged 5.49% during intraday trading on Monday, marking a significant upward movement for the company's shares.The rally follows the market's digestion of the company's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179140923","title":"Giant Biogene names Au-Yeung Nelly as Joint Company Secretary, Authorised Representative and Process Agent","url":"https://stock-news.laohu8.com/highlight/detail?id=1179140923","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179140923?lang=en_us&edition=fundamental","pubTime":"2026-04-08 17:42","pubTimestamp":1775641322,"startTime":"0","endTime":"0","summary":"Giant Biogene Holding Co., Ltd announced that Ms. Yuen Wing Yan, Winnie has resigned as Joint Company Secretary, Authorised Representative under Listing Rule 3.05 and Process Agent under Hong Kong’s...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108713062","title":"GIANT BIOGENE Appoints Co-Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=1108713062","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108713062?lang=en_us&edition=fundamental","pubTime":"2026-04-08 17:36","pubTimestamp":1775640979,"startTime":"0","endTime":"0","summary":"GIANT BIOGENE (02367) announced that Ms. Yuan Yingxin has resigned from her positions as the company's co-company secretary and authorized representative under the Hong Kong Stock Exchange's Listing...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","02367","BK1207","SG9999004311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625914000","title":"Giant Biogene appoints Au-Yeung Nelly as joint company secretary, authorized representative and process agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2625914000","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625914000?lang=en_us&edition=fundamental","pubTime":"2026-04-08 17:28","pubTimestamp":1775640480,"startTime":"0","endTime":"0","summary":"Giant Biogene named Au-Yeung Nelly joint company secretary, authorized representative, process agent in Hong Kong, effective April 8, 2026.Au-Yeung is senior manager, corporate services, at Tricor Services, with more than 10 years of corporate secretarial experience.Yan Yubo continues as other joint company secretary.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Giant Biogene Holding Co Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDLbFsmV4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367","LU2488822045.USD","SG9999004311.SGD","BK1207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160860105","title":"GIANT BIOGENE Keeps Issued Share Count Steady at 1.07 Billion in March; Public Float Remains Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1160860105","media":"Bulletin Express","labels":["SGX","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160860105?lang=en_us&edition=fundamental","pubTime":"2026-04-02 16:46","pubTimestamp":1775119601,"startTime":"0","endTime":"0","summary":"Giant Biogene Holding Co., Ltd. filed its Monthly Return for Equity Issuer for the period ended 31 March 2026, showing no changes in authorised or issued share capital during the month. Authorised /...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179050763","title":"GIANT BIOGENE Reports First Post-IPO Profit Decline; Can Its Foray into Medical Aesthetics Weave a New Growth Tale?","url":"https://stock-news.laohu8.com/highlight/detail?id=1179050763","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179050763?lang=en_us&edition=fundamental","pubTime":"2026-04-01 17:41","pubTimestamp":1775036494,"startTime":"0","endTime":"0","summary":"GIANT BIOGENE, a leading domestic producer of recombinant collagen, went public on the Hong Kong Stock Exchange in November 2022. With its high-performance growth, the company's market capitalization...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367","SG9999004311.SGD","BK1207","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622544805","title":"Giant Biogene Holding SEHK 2367 Valuation Check After Weaker Earnings And Adjusted Dividends","url":"https://stock-news.laohu8.com/highlight/detail?id=2622544805","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622544805?lang=en_us&edition=fundamental","pubTime":"2026-03-28 02:14","pubTimestamp":1774635277,"startTime":"0","endTime":"0","summary":"Giant Biogene Holding (SEHK:2367) released full year 2025 results, reporting revenue and net income below the prior year. The company also proposed a reduced final ordinary dividend alongside a separate special dividend for shareholders.\nSee our latest analysis for Giant Biogene Holding.\nDespite the latest earnings release and the mix of a reduced ordinary dividend with a separate special dividend, Giant Biogene Holding’s 1-year total shareholder return of 56.34% decline and 3-year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/household/hkg-2367/giant-biogene-holding-shares/news/giant-biogene-holding-sehk-2367-valuation-check-after-weaker","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/household/hkg-2367/giant-biogene-holding-shares/news/giant-biogene-holding-sehk-2367-valuation-check-after-weaker","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","LU2488822045.USD","SG9999004311.SGD","BK1207","02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163139741","title":"Analysis of GIANT BIOGENE's 2025 Annual Report: Growth Myth Fades, Six Major Risks Highlight Transition Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=1163139741","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163139741?lang=en_us&edition=fundamental","pubTime":"2026-03-27 16:01","pubTimestamp":1774598480,"startTime":"0","endTime":"0","summary":"GIANT BIOGENE, once hailed as the \"first recombinant collagen stock,\" delivered an unexpectedly disappointing performance in 2025 after years of rapid expansion. The leading Chinese recombinant...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","02367","SG9999004311.SGD","BK1207"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xajuzi.com","stockEarnings":[{"period":"1week","weight":-0.0572},{"period":"1month","weight":0.0273},{"period":"3month","weight":-0.1243},{"period":"6month","weight":-0.2551},{"period":"1year","weight":-0.6452},{"period":"ytd","weight":-0.119}],"compareEarnings":[{"period":"1week","weight":-0.0163},{"period":"1month","weight":0.0006},{"period":"3month","weight":-0.0227},{"period":"6month","weight":-0.0229},{"period":"1year","weight":0.107},{"period":"ytd","weight":0.013}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Giant Biogene Holding Co Ltd is an investment holding company primarily engaged in the research, development, manufacture and sale of bioactive material-based beauty and health products. The Company's main products include professional skin treatment products such as functional skincare products and medical dressings, as well as functional foods and others. The Company primarily conducts its businesses in domestic market.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.063759},{"month":2,"riseRate":0.75,"avgChangeRate":0.082298},{"month":3,"riseRate":0.75,"avgChangeRate":0.049732},{"month":4,"riseRate":0.75,"avgChangeRate":0.023751},{"month":5,"riseRate":0.25,"avgChangeRate":-0.044962},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.053764},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.046799},{"month":8,"riseRate":0.666667,"avgChangeRate":0.018731},{"month":9,"riseRate":0.666667,"avgChangeRate":0.061782},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.126143},{"month":11,"riseRate":0.333333,"avgChangeRate":0.019827},{"month":12,"riseRate":0.25,"avgChangeRate":0.047101}],"exchange":"SEHK","name":"GIANT BIOGENE","nameEN":"GIANT BIOGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GIANT BIOGENE(02367),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GIANT BIOGENE(02367) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GIANT BIOGENE,02367,GIANT BIOGENE股票,GIANT BIOGENE股票老虎,GIANT BIOGENE股票老虎国际,GIANT BIOGENE行情,GIANT BIOGENE股票行情,GIANT BIOGENE股价,GIANT BIOGENE股市,GIANT BIOGENE股票价格,GIANT BIOGENE股票交易,GIANT BIOGENE股票购买,GIANT BIOGENE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GIANT BIOGENE(02367),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GIANT BIOGENE(02367) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}